4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-021477
Chief Business Officer sold 45,000 shares at $31.64 ($1,423,800)
- Chief Business Officer acquired 45,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Martin Michael Robert · Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-01 | Exercise or conversion : show line 1 in the form | +45,000 | $3.20 | $144,000 | 221,861 | D |
| 2021-11-01 | Sale : show line 2 in the form | −45,000 | $31.64 | $1,423,800 | 176,861 | D |
| Open-market sales · 45,000 sh · avg $31.64 · $1,423,800 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-01 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −45,000 | 0 | D |
Loading xslF345X03/wf-form4_163597080368439.xml…